Pancreatic Cancer Diagnosis and Staging
Diagnosing pancreatic cancer involves imaging studies (CT, MRI, endoscopic ultrasound), biopsy and histopathological analysis, and tumor marker testing (CA 19-9). Staging determines whether the tumor is resectable (can be surgically removed), locally advanced, or metastatic, and this classification drives treatment decisions.
For patients considering treatment in Cuba, the diagnostic review requires complete staging information, pathology reports from biopsies or surgeries, imaging studies, tumor marker results, and prior treatment summaries. Cuban oncology centers may conduct additional diagnostic work to confirm staging and biomarker status before recommending a treatment plan.
Accurate staging is particularly important for pancreatic cancer because treatment options differ dramatically between resectable, locally advanced, and metastatic disease. SMC Salud's coordinators help patients assemble the necessary documentation for a thorough eligibility review.
All Sections — Pancreatic Cancer
Medically Reviewed
Dr. Marta Rodríguez
MD, Oncology — CIM Havana
Last reviewed: August 31, 2026
Medical References
- [1]American Cancer Society. Pancreatic Cancer Facts & Figures.
- [2]World Health Organization. Cancer Fact Sheets: Pancreatic Cancer. GLOBOCAN 2022.
- [3]Cuba's Center of Molecular Immunology (CIM). CIMAher (Nimotuzumab) Documentation.
This content has been medically reviewed by qualified physicians and follows SMC Salud's editorial policy for health information. Medical content is for informational purposes and does not replace professional medical advice.
Begin Your Path to Healing
Submit your inquiry and our international patient coordination team will review your case and respond within 24–48 hours with a personalized treatment recommendation.